Site icon Wall Street Business News

TransUnion Announces First Quarter 2025 Results

CHICAGO, April 24, 2025 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) (the “Company”) today announced financial results for the quarter ended March 31, 2025.

First Quarter 2025 Results

Revenue:

Earnings:

“In the first quarter, TransUnion delivered strong results that again exceeded financial guidance,” said Chris Cartwright, President and CEO. “U.S. Markets revenue grew 9 percent against subdued market conditions, led by strong mortgage and accelerating non-mortgage Financial Services and Emerging Verticals growth. International grew 6 percent on a constant currency basis, with high-single digit growth across most markets and India up low-single digits as anticipated.”

“We are maintaining our 2025 organic constant currency revenue guidance of 4.5 to 6 percent, balancing strong outperformance in the first quarter against increasing market risks. We are actively monitoring conditions but to-date have not experienced softening volumes in our business.”

“We believe we are well-positioned to navigate potential economic softening. We have a proven track record of delivering revenue growth through economic cycles, supported by a diversified and high-growth portfolio across solutions, verticals and geographies. Should conditions deteriorate, we are prepared to prudently manage costs while prioritizing the completion of our business transformation to deliver structural cost savings and accelerate innovation.”

First Quarter 2025 Segment Results

Segment revenue and Adjusted EBITDA for the first quarter of 2025 and the related growth rates compared with the first quarter of 2024 were as follows:

 (in millions) First Quarter
2025
  Reported
Growth Rate
  Constant
Currency
Growth Rate
U.S. Markets:          
Financial Services $ 404     15 %   15 %
Emerging Verticals   315     6 %   6 %
Consumer Interactive   138     (1 )%   (1 )%
Total U.S. Markets Revenue $ 857     9 %   9 %
           
U.S. Markets Adjusted EBITDA $ 320     12 %   12 %
           
International:          
Canada $ 38     %   7 %
Latin America   33     %   7 %
United Kingdom   59     9 %   9 %
Africa   17     12 %   10 %
India   69     (3 )%   1 %
Asia Pacific   27     7 %   8 %
Total International Revenue $ 242     2 %   6 %
           
International Adjusted EBITDA $ 110     3 %   7 %


Liquidity and Capital Resources

Cash and cash equivalents was $610 million at March 31, 2025 and $679 million at December 31, 2024.

For the three months ended March 31, 2025, cash provided by operating activities was $53 million, compared with $54 million in 2024. The decrease in cash provided by operating activities was primarily due to the timing of accounts receivable collections and higher bonus payouts in 2025 compared with 2024, mostly offset by improved operating performance and lower interest expense. For the three months ended March 31, 2025, cash used in investing activities was $87 million, compared with $62 million in 2024. The increase in cash used in investing activities was primarily due to a current year investment in a note receivable and an increase in capital expenditures. For the three months ended March 31, 2025, capital expenditures were $68 million, compared with $62 million in 2024. Capital expenditures as a percent of revenue represented 6% for each of the three months ended March 31, 2025 and 2024. For the three months ended March 31, 2025, cash used in financing activities was $41 million, compared with $31 million in 2024. Cash used in financing activities was higher primarily due to stock buybacks in 2025.

Second Quarter and Full Year 2025 Outlook

Our guidance is based on a number of assumptions that are subject to change, many of which are outside of the control of the Company, including general macroeconomic conditions, interest rates and inflation. There are numerous evolving factors that we may not be able to accurately predict. There can be no assurance that the Company will achieve the results expressed by this guidance.

    Three Months Ended
June 30, 2025
  Twelve Months Ended
December 31, 2025
(in millions, except per share data)   Low   High   Low   High
Revenue, as reported   $ 1,076     $ 1,095     $ 4,358     $ 4,417  
Revenue growth1:                
As reported     3 %     5 %     4 %     5.5 %
Constant currency1, 2     4 %     6 %     5 %     6 %
Organic constant currency1, 3     3 %     5 %     4.5 %     6 %
                 
Net income attributable to TransUnion   $ 69     $ 77     $ 383     $ 411  
Net income attributable to TransUnion growth   (18 )%   (9 )%     35 %     44 %
Net income attributable to TransUnion margin     6.5 %     7.1 %     8.8 %     9.3 %
                 
Diluted Earnings per Share   $ 0.35     $ 0.39     $ 1.92     $ 2.06  
Diluted Earnings per Share growth   (20 )%   (10 )%     33 %     43 %
                 
Adjusted EBITDA, as reported5   $ 375     $ 386     $ 1,549     $ 1,590  
Adjusted EBITDA growth, as reported4     %     3 %     3 %     6 %
Adjusted EBITDA margin     34.8 %     35.3 %     35.6 %     36.0 %
                 
Adjusted Diluted Earnings per Share5   $ 0.95     $ 0.99     $ 3.93     $ 4.08  
Adjusted Diluted Earnings per Share growth   (4 )%     %     %     4 %
  1. Additional revenue growth assumptions:
    1. The impact of changing exchange rates is expected to be approximately 1 point of headwind for Q2 2025 and approximately 1 point of headwind for FY 2025.
    2. The impact of the recent acquisition is expected to have approximately 1 point of benefit for Q2 2025 and less than 1 point of benefit for FY 2025.
    3. The impact of mortgage is expected to be approximately 2 points of benefit for Q2 2025 and 2 points of benefit for FY 2025.
    4. Constant currency growth rates assume foreign currency exchange rates are consistent between years. This allows financial results to be evaluated without the impact of fluctuations in foreign currency exchange rates.
    5. Organic constant currency growth rates are constant currency growth excluding inorganic growth. Inorganic growth represents growth attributable to the first twelve months of activity for recent business acquisitions.
    6. Additional Adjusted EBITDA assumptions:
      1. The impact of changing foreign currency exchange rates is expected to have approximately 1 point of headwind for Q2 2025 and approximately 1 point of headwind for FY 2025.
      2. For a reconciliation of the above non-GAAP financial measures to the most directly comparable GAAP financial measures, refer to Schedule 7 of this Earnings Release.
      3. Earnings Webcast Details

        In conjunction with this release, TransUnion will host a conference call and webcast today at 8:30 a.m. Central Time to discuss the business results for the quarter and certain forward-looking information. This session and the accompanying presentation materials may be accessed at www.transunion.com/tru. A replay of the call will also be available at this website following the conclusion of the call.

        About TransUnion (NYSE: TRU)

        TransUnion is a global information and insights company with over 13,000 associates operating in more than 30 countries. We make trust possible by ensuring each person is reliably represented in the marketplace. We do this with a Tru picture of each person: an actionable view of consumers, stewarded with care. Through our acquisitions and technology investments we have developed innovative solutions that extend beyond our strong foundation in core credit into areas such as marketing, fraud, risk and advanced analytics. As a result, consumers and businesses can transact with confidence and achieve great things. We call this Information for Good® — and it leads to economic opportunity, great experiences and personal empowerment for millions of people around the world.

        http://www.transunion.com/business

        Availability of Information on TransUnion’s Website

        Investors and others should note that TransUnion routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the TransUnion Investor Relations website. While not all of the information that the Company posts to the TransUnion Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in TransUnion to review the information that it shares on www.transunion.com/tru.

        Forward-Looking Statements

        This earnings release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the current beliefs and expectations of TransUnion’s management and are subject to significant risks and uncertainties. Actual results may differ materially from those described in the forward-looking statements. Any statements made in this earnings release that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements. Forward-looking statements include information concerning possible or assumed future results of operations, including our guidance and descriptions of our business plans and strategies. These statements often include words such as “anticipate,” “expect,” “guidance,” “suggest,” “plan,” “believe,” “intend,” “estimate,” “target,” “project,” “should,” “could,” “would,” “may,” “will,” “forecast,” “outlook,” “potential,” “continues,” “seeks,” “predicts,” or the negatives of these words and other similar expressions.

        Factors that could cause actual results to differ materially from those described in the forward-looking statements, or that could materially affect our financial results or such forward-looking statements include:

      There may be other factors, many of which are beyond our control, that may cause our actual results to differ materially from the forward-looking statements, including factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2024, and any subsequent Quarterly Report on Form 10-Q or Current Report on Form 8-K filed with the Securities and Exchange Commission. You should evaluate all forward-looking statements made in this report in the context of these risks and uncertainties.

      The forward-looking statements contained in this earnings release speak only as of the date of this earnings release. We undertake no obligation to publicly release the result of any revisions to these forward-looking statements to reflect the impact of events or circumstances that may arise after the date of this earnings release.

       
      TRANSUNION AND SUBSIDIARIES
      Consolidated Balance Sheets (Unaudited)
      (in millions, except per share data)
       
          March 31,
      2025
        December 31,
      2024
      Assets        
      Current assets:        
      Cash and cash equivalents   $ 609.9     $ 679.5  
      Trade accounts receivable, net of allowance of $24.4 and $19.9     882.3       798.9  
      Other current assets     326.2       323.4  
      Total current assets     1,818.4       1,801.8  
      Property, plant and equipment, net of accumulated depreciation and amortization of $527.6 and $506.3     199.8       203.5  
      Goodwill     5,162.7       5,144.3  
      Other intangibles, net of accumulated amortization of $2,421.7 and $2,294.5     3,205.6       3,257.5  
      Other assets     562.6       577.7  
      Total assets   $ 10,949.1     $ 10,984.8  
      Liabilities and stockholders’ equity        
      Current liabilities:        
      Trade accounts payable   $ 325.6     $ 294.6  
      Current portion of long-term debt     70.6       70.6  
      Other current liabilities     492.3       694.4  
      Total current liabilities     888.5       1,059.6  
      Long-term debt     5,060.2       5,076.6  
      Deferred taxes     386.4       415.3  
      Other liabilities     121.5       114.5  
      Total liabilities     6,456.6       6,666.0  
      Stockholders’ equity:        
      Preferred stock, $0.01 par value; 100.0 million shares authorized; none issued or outstanding as of March 31, 2025 and December 31, 2024, respectively            
      Common stock, $0.01 par value; 1.0 billion shares authorized at March 31, 2025 and December 31, 2024, 201.7 million and 201.5 million shares issued at March 31, 2025 and December 31, 2024, respectively, and 195.1 million and 194.9 million shares outstanding as of March 31, 2025 and December 31, 2024, respectively     2.0       2.0  
      Additional paid-in capital     2,595.1       2,558.9  
      Treasury stock at cost; 6.7 million and 6.6 million shares at March 31, 2025 and December 31, 2024, respectively     (340.1 )     (334.6 )
      Retained earnings     2,484.5       2,357.9  
      Accumulated other comprehensive loss     (355.7 )     (367.2 )
      Total TransUnion stockholders’ equity     4,385.8       4,217.0  
      Noncontrolling interests     106.7       101.8  
      Total stockholders’ equity     4,492.5       4,318.8  
      Total liabilities and stockholders’ equity   $ 10,949.1     $ 10,984.8  
       
      TRANSUNION AND SUBSIDIARIES
      Consolidated Statements of Operations (Unaudited)
      (in millions, except per share data)
       
          Three Months Ended March 31,
            2025       2024  
      Revenue   $ 1,095.7     $ 1,021.2  
      Operating expenses        
      Cost of services (exclusive of depreciation and amortization below)     445.6       406.3  
      Selling, general and administrative     256.8       305.6  
      Depreciation and amortization     138.9       134.0  
      Restructuring           18.2  
      Total operating expenses     841.4       864.1  
      Operating income     254.4       157.2  
      Non-operating income and (expense)        
      Interest expense     (56.1 )     (68.7 )
      Interest income     8.6       5.4  
      Earnings from equity method investments     4.3       4.7  
      Other income and (expense), net     (17.4 )     (15.7 )
      Total non-operating income and (expense)     (60.6 )     (74.1 )
      Income before income taxes     193.8       83.0  
      Provision for income taxes     (41.0 )     (13.0 )
      Net income     152.7       70.0  
      Less: net income attributable to noncontrolling interests     (4.7 )     (4.9 )
      Net income attributable to TransUnion   $ 148.1     $ 65.1  
               
      Basic earnings per common share from:        
      Net income attributable to TransUnion   $ 0.76     $ 0.34  
      Diluted earnings per common share from:        
      Net income attributable to TransUnion   $ 0.75     $ 0.33  
      Weighted-average shares outstanding:        
      Basic     195.1       194.1  
      Diluted     197.3       195.3  

      As a result of displaying amounts in millions, rounding differences may exist in the table above.

       
      TRANSUNION AND SUBSIDIARIES
      Consolidated Statements of Cash Flows (Unaudited)
      (in millions)
       
          Three Months Ended March 31,
            2025       2024  
      Cash flows from operating activities:        
      Net income   $ 152.7     $ 70.0  
      Adjustments to reconcile net income to net cash provided by operating activities:        
      Depreciation and amortization     138.9       134.0  
      Loss on repayment of loans           0.7  
      Deferred taxes     (22.5 )     (27.1 )
      Stock-based compensation     30.3       24.1  
      Other     15.2       (1.2 )
      Changes in assets and liabilities:        
      Trade accounts receivable     (88.9 )     (60.7 )
      Other current and long-term assets     3.8       43.7  
      Trade accounts payable     29.7       28.7  
      Other current and long-term liabilities     (206.7 )     (158.2 )
      Cash provided by operating activities     52.5       54.0  
      Cash flows from investing activities:        
      Capital expenditures     (68.4 )     (62.4 )
      Proceeds from sale/maturities of other investments     0.2        
      Investments in nonconsolidated affiliates and notes receivable     (20.0 )     (1.2 )
      Other     1.6       1.2  
      Cash used in investing activities     (86.6 )     (62.4 )
      Cash flows from financing activities:        
      Proceeds from term loans           264.1  
      Repayments of term loans           (257.1 )
      Repayments of debt     (17.7 )     (14.6 )
      Debt financing fees           (4.7 )
      Dividends to shareholders     (22.6 )     (20.8 )
      Proceeds from issuance of common stock     10.6       12.4  
      Employee taxes paid on restricted stock units recorded as treasury stock     (5.5 )     (10.6 )
      Repurchase of common stock     (5.4 )      
      Cash used in financing activities     (40.6 )     (31.3 )
      Effect of exchange rate changes on cash and cash equivalents     5.1       (2.9 )
      Net change in cash and cash equivalents     (69.6 )     (42.6 )
      Cash and cash equivalents, beginning of period     679.5       476.2  
      Cash and cash equivalents, end of period   $ 609.9     $ 433.6  

      As a result of displaying amounts in millions, rounding differences may exist in the table above.

      TRANSUNION AND SUBSIDIARIES
      Non-GAAP Financial Measures

      We present Consolidated Adjusted EBITDA, Consolidated Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted Earnings per Share, Adjusted Provision for Income Taxes, Adjusted Effective Tax Rate and Leverage Ratio for all periods presented. These are important financial measures for the Company but are not financial measures as defined by GAAP. These financial measures should be reviewed in conjunction with the relevant GAAP financial measures and are not presented as alternative measures of GAAP. Other companies in our industry may define or calculate these measures differently than we do, limiting their usefulness as comparative measures. Because of these limitations, these non-GAAP financial measures should not be considered in isolation or as substitutes for performance measures calculated in accordance with GAAP, including operating income, operating margin, effective tax rate, net income attributable to the Company, diluted earnings per share or cash provided by operating activities. Reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures are presented in the tables below.

      We present Consolidated Adjusted EBITDA, Consolidated Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted Earnings per Share, Adjusted Provision for Income Taxes and Adjusted Effective Tax Rate as supplemental measures of our operating performance because these measures eliminate the impact of certain items that we do not consider indicative of our cash operations and ongoing operating performance. These are measures frequently used by securities analysts, investors and other interested parties in their evaluation of the operating performance of companies similar to ours.

      Our board of directors and executive management team use Adjusted EBITDA as an incentive compensation measure for most eligible employees and Adjusted Diluted Earnings per Share as an incentive compensation measure for certain of our senior executives.

      Under the credit agreement governing our Senior Secured Credit Facility, our ability to engage in activities such as incurring additional indebtedness, making investments and paying dividends is tied to our Leverage Ratio which is partially based on Adjusted EBITDA. Investors also use our Leverage Ratio to assess our ability to service our debt and make other capital allocation decisions.

      Consolidated Adjusted EBITDA

      Management has excluded the following items from net income attributable to TransUnion in order to calculate Adjusted EBITDA for the periods presented:

      Consolidated Adjusted EBITDA Margin

      Management defines Consolidated Adjusted EBITDA Margin as Consolidated Adjusted EBITDA divided by total revenue as reported.

      Adjusted Net Income

      Management has excluded the following items from net income attributable to TransUnion in order to calculate Adjusted Net Income for the periods presented:

      Adjusted Diluted Earnings Per Share

      Management defines Adjusted Diluted Earnings per Share as Adjusted Net Income divided by the weighted-average diluted shares outstanding.

      Adjusted Provision for Income Taxes

      Management has excluded the following items from our provision for income taxes for the periods presented:

      Adjusted Effective Tax Rate

      Management defines Adjusted Effective Tax Rate as Adjusted Provision for Income Taxes divided by Adjusted income before income taxes. We calculate adjusted income before income taxes by excluding the pre-tax adjustments in the calculation of Adjusted Net Income discussed above and noncontrolling interest related to these pre-tax adjustments from income before income taxes.

      Leverage Ratio

      Management defines Leverage Ratio as net debt divided by Consolidated Adjusted EBITDA for the most recent twelve-month period including twelve months of Adjusted EBITDA from significant acquisitions. Net debt is defined as total debt less cash and cash equivalents as reported on the balance sheet as of the end of the period.

      This earnings release presents constant currency growth rates assuming foreign currency exchange rates are consistent between years. This allows financial results to be evaluated without the impact of fluctuations in foreign currency exchange rates. This earnings release also presents organic constant currency growth rates, which assumes consistent foreign currency exchange rates between years and also eliminates the impact of our recent acquisitions. This allows financial results to be evaluated without the impact of fluctuations in foreign currency exchange rates and the impacts of recent acquisitions.

      Free cash flow is defined as cash provided by operating activities less capital expenditures and is a measure we may refer to.

      Refer to Schedules 1 through 7 for a reconciliation of our non-GAAP financial measures to the most directly comparable GAAP financial measure.

       
      SCHEDULE 1
      TRANSUNION AND SUBSIDIARIES
      Revenue and Adjusted EBITDA growth rates as Reported, CC, and Organic CC
      (Unaudited)
       
          For the Three Months Ended March 31, 2025
      compared with
      the Three Months Ended March 31, 2024
          Reported   CC Growth1   Organic CC
      Growth2
      Revenue:            
      Consolidated   7.3 %   8.1 %   8.1 %
      U.S. Markets   8.6 %   8.6 %   8.6 %
      Financial Services   14.7 %   14.7 %   14.7 %
      Emerging Verticals   5.8 %   5.8 %   5.8 %
      Consumer Interactive   (0.8 )%   (0.8 )%   (0.8 )%
      International   2.5 %   6.0 %   6.0 %
      Canada   0.4 %   6.9 %   6.9 %
      Latin America   (0.5 )%   6.9 %   6.9 %
      United Kingdom   8.6 %   9.5 %   9.5 %
      Africa   11.9 %   9.5 %   9.5 %
      India   (3.3 )%   0.9 %   0.9 %
      Asia Pacific   7.0 %   8.0 %   8.0 %
                   
      Adjusted EBITDA:            
      Consolidated   10.9 %   12.3 %   12.3 %
      U.S. Markets   12.3 %   12.3 %   12.3 %
      International   2.8 %   7.3 %   7.3 %
      1. Constant Currency (“CC”) growth rates assume foreign currency exchange rates are consistent between years. This allows financial results to be evaluated without the impact of fluctuations in foreign currency exchange rates.
      2. We have no inorganic revenue or Adjusted EBITDA for the periods presented. Organic CC growth rate is the CC growth rate less the inorganic growth rate.
       
      SCHEDULE 2
      TRANSUNION AND SUBSIDIARIES
      Consolidated and Segment Revenue, Adjusted EBITDA, and Adjusted EBITDA Margin (Unaudited)
      (dollars in millions)
       
        Three Months Ended March 31,
          2025       2024  
      Revenue:      
      U.S. Markets gross revenue      
      Financial Services $ 403.6     $ 351.7  
      Emerging Verticals   314.9       297.5  
      Consumer Interactive   138.2       139.3  
      U.S. Markets gross revenue $ 856.6     $ 788.6  
             
      International gross revenue      
      Canada $ 37.8     $ 37.7  
      Latin America   32.8       32.9  
      United Kingdom   58.8       54.2  
      Africa   16.9       15.1  
      India   68.8       71.1  
      Asia Pacific   27.0       25.3  
      International gross revenue $ 242.2     $ 236.3  
             
      Total gross revenue $ 1,098.8     $ 1,024.9  
             
      Intersegment revenue eliminations      
      U.S. Markets $ (1.6 )   $ (2.3 )
      International   (1.5 )     (1.5 )
      Total intersegment revenue eliminations $ (3.1 )   $ (3.7 )
             
      Total revenue as reported $ 1,095.7     $ 1,021.2  
             
      Adjusted EBITDA:      
      U.S. Markets $ 320.1     $ 285.2  
      International   109.8       106.8  
      Corporate   (32.8 )     (33.9 )
      Adjusted EBITDA Margin:1      
      U.S. Markets   37.4 %     36.2 %
      International   45.3 %     45.2 %
      1. Segment Adjusted EBITDA Margins are calculated using segment gross revenue and segment Adjusted EBITDA. Consolidated Adjusted EBITDA Margin is calculated using total revenue as reported and consolidated Adjusted EBITDA.
        Three Months Ended March 31,
          2025       2024  
      Reconciliation of Net income attributable to TransUnion to consolidated Adjusted EBITDA:      
      Net income attributable to TransUnion $ 148.1     $ 65.1  
      Net interest expense   47.5       63.2  
      Provision for income taxes   41.0       13.0  
      Depreciation and amortization   138.9       134.0  
      EBITDA $ 375.5     $ 275.4  
      Adjustments to EBITDA:      
      Stock-based compensation   30.3       24.1  
      Mergers and acquisitions, divestitures and business optimization1   17.9       9.2  
      Accelerated technology investment2   20.0       18.5  
      Operating model optimization program3   9.8       24.4  
      Net other4   (56.4 )     6.5  
      Total adjustments to EBITDA $ 21.7     $ 82.8  
      Consolidated Adjusted EBITDA $ 397.1     $ 358.2  
             
      Net income attributable to TransUnion margin   13.5 %     6.4 %
      Consolidated Adjusted EBITDA margin5   36.2 %     35.1 %

      As a result of displaying amounts in millions, rounding differences may exist in the tables above and footnotes below.

      1.   Mergers and acquisitions, divestitures and business optimization consisted of the following adjustments:
          Three Months Ended March 31,
            2025       2024  
      Transaction and integration costs   $ 5.3     $ 2.2  
      Fair value and impairment adjustments     12.6       0.1  
      Post-acquisition adjustments           6.9  
      Total mergers and acquisitions, divestitures and business optimization   $ 17.9     $ 9.2  
      2.   Represents expenses associated with our accelerated technology investment to migrate to the cloud. There are three components of the accelerated technology investment: (i) building foundational capabilities, which includes establishing a modern, API-based and services-oriented software architecture, (ii) the migration of each application and customer data to the new enterprise platform, including the redundant software costs during the migration period, as well as the efforts to decommission the legacy system, and (iii) program enablement, which includes dedicated resources to support the planning and execution of the program. The amounts for each category of cost are as follows:
          Three Months Ended March 31,
            2025       2024  
      Foundational Capabilities   $ 7.4     $ 6.8  
      Migration Management     12.6       10.1  
      Program Enablement           1.7  
      Total accelerated technology investment   $ 20.0     $ 18.5  
      3.   Operating model optimization consisted of the following adjustments:
          Three Months Ended March 31,
            2025       2024  
      Employee separation   $     $ 16.8  
      Facility exit           1.4  
      Business process optimization     9.8       6.2  
      Total operating model optimization   $ 9.8     $ 24.4  
      4.   Net other consisted of the following adjustments: 
          Three Months Ended March 31,
            2025       2024  
      Deferred loan fee expense from debt prepayments and refinancing   $ (0.1 )   $ 3.1  
      Other debt financing expenses     0.5       0.6  
      Currency remeasurement on foreign operations     (0.6 )     2.6  
      Legal and regulatory expenses, net     (56.0 )      
      Other non-operating (income) expense     (0.3 )     0.2  
      Total other adjustments   $ (56.4 )   $ 6.5  
      5.   Consolidated Adjusted EBITDA margin is calculated by dividing Consolidated Adjusted EBITDA by total revenue.
       
      SCHEDULE 3
      TRANSUNION AND SUBSIDIARIES
      Adjusted Net Income and Adjusted Diluted Earnings Per Share (Unaudited)
      (in millions, except per share data)
       
          Three Months Ended March 31,
            2025       2024  
      Income attributable to TransUnion   $ 148.1     $ 65.1  
               
      Weighted-average shares outstanding:        
      Basic     195.1       194.1  
      Diluted     197.3       195.3  
               
      Basic earnings per common share from:        
      Net income attributable to TransUnion   $ 0.76     $ 0.34  
      Diluted earnings per common share from:        
      Net income attributable to TransUnion   $ 0.75     $ 0.33  
               
      Reconciliation of Net income attributable to TransUnion to Adjusted Net Income:        
      Net income attributable to TransUnion   $ 148.1     $ 65.1  
      Adjustments before income tax items:        
      Amortization of certain intangible assets1     70.9       72.0  
      Stock-based compensation     30.3       24.1  
      Mergers and acquisitions, divestitures and business optimization2     17.9       9.2  
      Accelerated technology investment3     20.0       18.5  
      Operating model optimization program4     9.8       24.4  
      Net other5     (56.7 )     5.9  
      Total adjustments before income tax items   $ 92.3     $ 154.3  
      Total adjustments for income taxes6     (32.7 )     (40.4 )
      Adjusted Net Income   $ 207.6     $ 179.0  
               
      Weighted-average shares outstanding:        
      Basic     195.1       194.1  
      Diluted     197.3       195.3  
               
      Adjusted Earnings per Share:        
      Basic   $ 1.06     $ 0.92  
      Diluted   $ 1.05     $ 0.92  
          Three Months Ended March 31,
            2025       2024  
      Reconciliation of Diluted earnings per share from Net income attributable to TransUnion to Adjusted Diluted Earnings per Share:        
      Diluted earnings per common share from:        
      Net income attributable to TransUnion   $ 0.75     $ 0.33  
      Adjustments before income tax items:        
      Amortization of certain intangible assets1     0.36       0.37  
      Stock-based compensation     0.15       0.12  
      Mergers and acquisitions, divestitures and business optimization2     0.09       0.05  
      Accelerated technology investment3     0.10       0.09  
      Operating model optimization program4     0.05       0.13  
      Net other5     (0.29 )     0.03  
      Total adjustments before income tax items   $ 0.47     $ 0.79  
      Total adjustments for income taxes6     (0.17 )     (0.21 )
      Adjusted Diluted Earnings per Share   $ 1.05     $ 0.92  

      Each component of earnings per share is calculated independently, therefore, rounding differences exist in the table above.

      1.   Consists of amortization of intangible assets from our 2012 change-in-control transaction and amortization of intangible assets established in business acquisitions after our 2012 change-in-control transaction.
      2.   Mergers and acquisitions, divestitures and business optimization consisted of the following adjustments:
          Three Months Ended March 31,
            2025       2024  
      Transaction and integration costs   $ 5.3     $ 2.2  
      Fair value and impairment adjustments     12.6       0.1  
      Post-acquisition adjustments           6.9  
      Total mergers and acquisitions, divestitures and business optimization   $ 17.9     $ 9.2  
      3.   Represents expenses associated with our accelerated technology investment to migrate to the cloud. There are three components of the accelerated technology investment: (i) building foundational capabilities which includes establishing a modern, API-based and services-oriented software architecture, (ii) the migration of each application and customer data to the new enterprise platform, including the redundant software costs during the migration period, as well as the efforts to decommission the legacy system, and (iii) program enablement, which includes dedicated resources to support the planning and execution of the program. The amounts for each category of cost are as follows:
          Three Months Ended March 31,
            2025       2024  
      Foundational Capabilities   $ 7.4     $ 6.8  
      Migration Management     12.6       10.1  
      Program Enablement           1.7  
      Total accelerated technology investment   $ 20.0     $ 18.5  
      4.   Operating model optimization consisted of the following adjustments:
          Three Months Ended March 31,
            2025       2024  
      Employee separation   $     $ 16.8  
      Facility exit           1.4  
      Business process optimization     9.8       6.2  
      Total operating model optimization   $ 9.8     $ 24.4  
      5.   Net other consisted of the following adjustments:
          Three Months Ended March 31,
            2025       2024  
      Deferred loan fee expense from debt prepayments and refinancing   $ (0.1 )   $ 3.1  
      Currency remeasurement on foreign operations     (0.6 )     2.6  
      Legal and regulatory expenses, net     (56.0 )      
      Other non-operating (income) and expense           0.2  
      Total other adjustments   $ (56.7 )   $ 5.9  
      6.   Total adjustments for income taxes represents the total of adjustments discussed to calculate the Adjusted Provision for Income Taxes.
       
      SCHEDULE 4
      TRANSUNION AND SUBSIDIARIES
      Adjusted Provision for Income Taxes and Adjusted Effective Tax Rate (Unaudited)
      (dollars in millions)
       
        Three Months Ended March 31,
          2025       2024  
      Income before income taxes $ 193.8     $ 83.0  
      Total adjustments before income tax items from Schedule 3   92.3       154.3  
      Adjusted income before income taxes $ 286.1     $ 237.3  
             
      Reconciliation of Provision for income taxes to Adjusted Provision for Income Taxes:      
      Provision for income taxes   (41.0 )     (13.0 )
      Adjustments for income taxes:      
      Tax effect of above adjustments   (32.3 )     (35.0 )
      Eliminate impact of excess tax expense for stock-based compensation   0.5       1.0  
      Other1   (0.9 )     (6.4 )
      Total adjustments for income taxes $ (32.7 )   $ (40.4 )
      Adjusted Provision for Income Taxes $ (73.7 )   $ (53.4 )
             
      Effective tax rate   21.2 %     15.7 %
      Adjusted Effective Tax Rate   25.8 %     22.5 %

      As a result of displaying amounts in millions, rounding differences may exist in the table above.

      1.   Other adjustments for income taxes include:
          Three Months Ended March 31,
            2025       2024  
      Deferred tax adjustments   $ (4.6 )   $ (5.1 )
      Valuation allowance adjustments     2.3       0.2  
      Return to provision, audit adjustments and reserves related to prior periods     1.0       (0.9 )
      Other adjustments     0.4       (0.5 )
      Total other adjustments   $ (0.9 )   $ (6.4 )
       
      SCHEDULE 5
      TRANSUNION AND SUBSIDIARIES
      Leverage Ratio (Unaudited)
      (dollars in millions)
       
          Trailing Twelve
      Months Ended
      March 31, 2025
      Reconciliation of Net income attributable to TransUnion to Consolidated Adjusted EBITDA:    
      Net income attributable to TransUnion   $ 367.3  
      Net interest expense     221.0  
      Provision for income taxes     126.9  
      Depreciation and amortization     542.6  
      EBITDA   $ 1,257.7  
      Adjustments to EBITDA:    
      Stock-based compensation   $ 127.5  
      Mergers and acquisitions, divestitures and business optimization1     35.2  
      Accelerated technology investment2     85.7  
      Operating model optimization program3     80.3  
      Net other4     (41.1 )
      Total adjustments to EBITDA   $ 287.6  
      Leverage Ratio Adjusted EBITDA   $ 1,545.3  
           
      Total debt   $ 5,130.8  
      Less: Cash and cash equivalents     609.9  
      Net Debt   $ 4,521.0  
           
      Ratio of Net Debt to Net income attributable to TransUnion     12.3  
      Leverage Ratio     2.9  

      As a result of displaying amounts in millions, rounding differences may exist in the table above.

      1.   Mergers and acquisitions, divestitures and business optimization consisted of the following adjustments:
          Trailing Twelve
      Months Ended
      March 31, 2025
      Transaction and integration costs   $ 14.2  
      Fair value and impairment adjustments     20.8  
      Post-acquisition adjustments     0.1  
      Total mergers and acquisitions, divestitures and business optimization   $ 35.2  
      2.   Represents expenses associated with our accelerated technology investment to migrate to the cloud. There are three components of the accelerated technology investment: (i) building foundational capabilities which includes establishing a modern, API-based and services-oriented software architecture, (ii) the migration of each application and customer data to the new enterprise platform including the redundant software costs during the migration period, as well as the efforts to decommission the legacy system, and (iii) program enablement, which includes dedicated resources to support the planning and execution of the program. The amounts for each category of cost are as follows:
          Trailing Twelve
      Months Ended
      March 31, 2025
      Foundational Capabilities   $ 36.3  
      Migration Management     45.6  
      Program Enablement     3.8  
      Total accelerated technology investment   $ 85.7  
      3.   Operating model optimization consisted of the following adjustments:
          Trailing Twelve
      Months Ended
      March 31, 2025
      Employee separation   $ 7.9  
      Facility exit     40.7  
      Business process optimization     31.7  
      Total operating model optimization   $ 80.3  
      4.   Net other consisted of the following adjustments:
          Trailing Twelve
      Months Ended
      March 31, 2025
      Deferred loan fee expense from debt prepayments and refinancings   $ 14.6  
      Other debt financing expenses     2.3  
      Currency remeasurement on foreign operations     (1.1 )
      Legal and regulatory expenses, net     (56.0 )
      Other non-operating (income) and expense     (1.0 )
      Total other adjustments   $ (41.1 )
       
      SCHEDULE 6
      TRANSUNION AND SUBSIDIARIES
      Segment Depreciation and Amortization (Unaudited)
      (in millions)
       
        Three Months Ended March 31,
          2025       2024  
             
      U.S. Markets $ 101.2     $ 100.8  
      International   36.6       32.2  
      Corporate   1.1       1.0  
      Total depreciation and amortization $ 138.9     $ 134.0  

      As a result of displaying amounts in millions, rounding differences may exist in the table above.

       
      SCHEDULE 7
      TRANSUNION AND SUBSIDIARIES
      Reconciliation of Non-GAAP Guidance (Unaudited)
      (in millions, except per share data)
       
        Three Months Ended
      June 30, 2025
        Twelve Months Ended
      December 31, 2025
        Low   High   Low   High
      Guidance reconciliation of Net income attributable to TransUnion to Adjusted EBITDA:              
      Net income attributable to TransUnion $ 69     $ 77     $ 383     $ 411  
      Interest, taxes and depreciation and amortization   220       224       917       929  
      EBITDA $ 290     $ 302     $ 1,299     $ 1,340  
      Stock-based compensation, mergers, acquisitions divestitures and business optimization-related expenses and other adjustments1   85       85       250       250  
      Adjusted EBITDA $ 375     $ 386     $ 1,549     $ 1,590  
                     
      Net income attributable to TransUnion margin   6.5 %     7.1 %     8.8 %     9.3 %
      Consolidated Adjusted EBITDA margin2   34.8 %     35.3 %     35.6 %     36.0 %
                     
      Guidance reconciliation of Diluted earnings per share to Adjusted Diluted Earnings per Share:              
      Diluted earnings per share $ 0.35     $ 0.39     $ 1.92     $ 2.06  
      Adjustments to diluted earnings per share1   0.60       0.60       2.00       2.01  
      Adjusted Diluted Earnings per Share $ 0.95     $ 0.99     $ 3.93     $ 4.08  

      As a result of displaying amounts in millions, rounding differences may exist in the table above.

      1. These adjustments include the same adjustments we make to our Adjusted EBITDA and Adjusted Net Income as discussed in the Non-GAAP Financial Measures section of our Earnings Release.
      2. Consolidated Adjusted EBITDA margin is calculated by dividing Consolidated Adjusted EBITDA by total revenue.


      Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow